UnitedHealthcare · Type 2 Diabetes

UnitedHealthcare coverage for Mounjaro (Type 2 Diabetes)

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

Age 18 and older
A1C of 6.5% or higher
Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

New T2DM diagnosis (diagnosed <= 2 years ago)

All of:

Submission of medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus

Plus any one of:

A1C >= 6.5%
Fasting plasma glucose (FPG) >= 126 mg/dL
2-hour plasma glucose >= 200 mg/dL during oral glucose tolerance test
Random plasma glucose >= 200 mg/dL in patient with classic symptoms of hyperglycemia or hyperglycemic crisis

Ongoing T2DM treatment (diagnosed > 2 years ago)

All of:

Submission of medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus
Patient diagnosed greater than 2 years ago

Documentation to bring

Medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus
For new diagnosis (<=2 years): at least one qualifying lab value (A1C >= 6.5%, FPG >= 126 mg/dL, 2-hr PG >= 200 mg/dL on OGTT, or random PG >= 200 mg/dL with classic hyperglycemia symptoms)
For ongoing treatment (>2 years): chart notes confirming T2DM diagnosis

Approval and renewal

Initial approval: 12 months
Renewal: every 12 months
To renew, the plan looks for Re-authorization may be based solely on previous claim/medication history, diagnosis codes (ICD-10), and/or claim logic via automated processes.

Not covered when

Not approved for weight loss; use solely for weight loss is not covered
Type 1 diabetes

Policy note: Mounjaro is described as a GIP/GLP-1 dual receptor agonist. The policy explicitly states these medications are not FDA approved for weight loss and that medications used for weight loss are typically excluded from benefit coverage. Adult-only indication per FDA label and per document background. Automated approval/re-approval processes may apply based on claim/medication history and ICD-10 codes. Supply limits may be in place.

Policy effective July 1, 2025 · verified June 2, 2026 · source: PA-Notification-Diabetes-Agents-GLP1-Receptor-Agonists.pdf

ACA Marketplace

Covered with requirements

What you need to qualify

Age 18 and older
A1C of 6.5% or higher
Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

New T2DM diagnosis (diagnosed <= 2 years ago)

All of:

Submission of medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus

Plus any one of:

A1C >= 6.5%
Fasting plasma glucose (FPG) >= 126 mg/dL
2-hour plasma glucose >= 200 mg/dL during oral glucose tolerance test
Random plasma glucose >= 200 mg/dL in patient with classic symptoms of hyperglycemia or hyperglycemic crisis

Ongoing T2DM treatment (diagnosed > 2 years ago)

All of:

Submission of medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus
Patient diagnosed greater than 2 years ago

Documentation to bring

Medical records (e.g., chart notes) confirming diagnosis of type 2 diabetes mellitus
For new diagnosis (<=2 years): at least one qualifying lab value (A1C >= 6.5%, FPG >= 126 mg/dL, 2-hr PG >= 200 mg/dL on OGTT, or random PG >= 200 mg/dL with classic hyperglycemia symptoms)
For ongoing treatment (>2 years): chart notes confirming T2DM diagnosis

Approval and renewal

Initial approval: 12 months
Renewal: every 12 months
To renew, the plan looks for Re-authorization may be based solely on previous claim/medication history, diagnosis codes (ICD-10), and/or claim logic via automated processes.

Not covered when

Not approved for weight loss; use solely for weight loss is not covered
Type 1 diabetes

Policy effective July 1, 2025 · verified June 2, 2026 · source: PA-Notification-Diabetes-Agents-GLP1-Receptor-Agonists.pdf

All Mounjaro policies under UnitedHealthcare · Check your card